Redwood City, California – Synthego, a leading provider of genome enineering solutions, today announced that genomic industry pioneer Dr. Jennifer Doudna has joined the company’s advisory board. Doudna, best known for co-inventing CRISPR, will advise Synthego on a variety of product, partnership, and business strategy initiatives to help amplify the company’s fast-growing impact in the genome engineering […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio® Sequel® Systems that are expected to be installed at Annoroad’s designated facility within the next several months, enhancing Annoroad’s large-scale genomic service capabilities across various fields within the life sciences such as agriculture, basic research, […]

Real-Time PCR workflow gains NF VALIDATION by AFNOR Certification for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England — Laboratories performing tests for poultry producers can simultaneously screen samples for Salmonella species, Typhimurium and Enteritidis using the first independently validated PCR test of its kind. Thermo Fisher Scientific, a market leader in culture […]

La Vista, NE – Streck, Inc. and Van Xuan Medical Technology, a pharmaceutical distributor in Ho Chi Minh City, Vietnam, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens […]

Today, KeyGene announces that it has further extended its global Next Generation Sequencing (NGS) patent estate. On February 20, 2018, the USPTO granted U.S. Patent Nos. 9,896,721; US 9,898,576; and US 9,898,577, entitled “Strategies for high throughput identification and detection of polymorphisms.” KeyGene’s NGS worldwide patent estate now comprises more than 25 issued patents in […]

San Diego, Calif., and Nanjing, JiangSu – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY® System for companion diagnostics and pharmacogenetic testing in China. As a leading pharmaceutical company with strong connections to China’s […]

Location: Cambridge First-to-market Edit-R CRISPRa arrayed crRNA libraries enable native gene overexpression for high-throughput gain-of-function screening Available as small gene families, bespoke collections, the druggable genome, or human genome-wide collection Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in the application of gene editing and gene modulation to deliver inspired cell […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware denied a motion to dismiss filed on December 14, 2017 by Oxford Nanopore Technologies, Inc., a wholly-owned subsidiary of Oxford Nanopore Technologies Ltd. ONT had sought to dismiss Pacific Biosciences’ complaint for […]

New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way for Future Growth Resulting Cost Savings to be Reinvested Back into the Business CINCINNATI — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the realignment of its business structure aimed at […]

New and updated assays increase application areas and improve performance MINNEAPOLIS — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use. The continued investment in […]